Gilead Sciences, Inc.Gilead Sciences, Inc.Gilead Sciences, Inc.

Gilead Sciences, Inc.

No trades
See on Supercharts
Market capitalization
‪83.93 B‬USD
‪5.66 B‬USD
‪27.06 B‬USD
‪1.25 B‬
Beta (1Y)
0.47

About Gilead Sciences, Inc.

CEO
Daniel P. O'Day
Website
Headquarters
Foster City
Employees (FY)
‪18 K‬
Founded
1987
ISIN
US3755581036
FIGI
BBG000CKGBP2
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GILD is 66.93 USD — it has decreased by 0.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Gilead Sciences, Inc. stocks are traded under the ticker GILD.
Gilead Sciences, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Gilead Sciences, Inc. has a max estimate of 121.00 USD and a min estimate of 69.00 USD.
GILD earnings for the last quarter are 2.29 USD whereas the estimation was 1.92 USD which accounts for 19.50% surprise. Estimated earnings for the next quarter are 1.76 USD. See more details about Gilead Sciences, Inc. earnings.
Gilead Sciences, Inc. revenue for the last quarter amounts to ‪7.05 B‬ USD despite the estimated figure of ‪6.81 B‬ USD. In the next quarter revenue is expected to reach ‪7.10 B‬ USD.
Yes, you can track Gilead Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, GILD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gilead Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GILD reached its all-time high on Jun 24, 2015 with the price of 123.37 USD, and its all-time low was 0.21 USD and was reached on Jun 8, 1994.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪18.00 K‬ employees. See our rating of the largest employees — is Gilead Sciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Gilead Sciences, Inc. EBITDA is ‪11.88 B‬ USD, and current EBITDA margin is 45.96%. See more stats in Gilead Sciences, Inc. financial statements.